Reported 1 day ago
Bio-Rad Laboratories, Inc. has made headlines for launching four new Droplet Digital PCR (ddPCR) instruments in 2025, expanding its offerings in life science research and clinical diagnostics. These advanced tools, including the QX Continuum and QX700 series, enhance applications in oncology and infectious disease, support gene therapy research with new ddPCR kits, and introduce innovative products for biopharmaceutical manufacturing. The company remains engaged in industry events, showcasing its technology advancements.
Source: YAHOO